Artificial Organ and Bionics Market - Global Industry Analysis and Share 2020

Continuous technological innovations coupled with high investments in healthcare are two key factors that fuel the global Artificial Organ and Bionics Market. Artificial organs refer to devices that are developed to replace natural organs in the human body. The need for organ transplant arises when a certain natural organ has either stopped working or doesn’t function properly. Artificial organs and artificial body parts are made from substances known as biomaterials.

Man made hazards and high frequency of accidents may propel the global artificial organ and bionics market during the forecast period (2014 to 2020). Artificial liver, artificial limbs, artificial pancreas, artificial heart, and artificial kidneys are examples of artificial organs that function exactly like natural organs when implanted in the human body. The application of electronics & mechanics in the field of medicine has led to newer innovations in developing artificial organs.

The worldwide artificial organ and bionics market is categorized on the basis of products, technologies, and regions. Based on products, the segments are artificial pancreas, artificial liver, artificial lungs, artificial heart, and artificial kidney. Medical bionics products are further subdivided into cardiac bionics, brain bionics, vision bionics, heart bionics, limb bionics, and exoskeleton bionics. Due to high prevalence of heart disorders worldwide, the segment for heart bionics holds the largest share in the overall market. The artificial lungs & kidney segments held considerable industry shares in 2013. These segments may grow substantially during the forecast period because of problems, such as alcohol abuse and consumption of drugs & cigarettes.

Browse Details of Report @ https://www.hexaresearch.com/research-report/artificial-organs-and-bionics-industry

On the basis of technologies, the industry is bifurcated into mechanical bionics and electronic bionics. Rapid technological advancements have led to the development of medical bionics that meets the challenges of organ failure. Mechanical bionics is mostly employed in the development of orthopedic body parts.

As per regions, the global artificial organ and bionics market is categorized into Europe, Asia Pacific, North America, and Rest of the World. North America led the industry in 2013. Factors that fuel this region are high investments in research & development and technological advancements. Growing geriatric population, rising cases of organ failure, and high incidence of accidents may contribute to regional growth over the forecast period. However, the Asia Pacific market is poised to grow rapidly over the next couple of years. This industry is driven by steady government support, medical tourism, and surging disposable incomes. Government support has led to improvements in healthcare infrastructures.

Companies in the worldwide artificial organ and bionics market are Second Sight Medical Product Inc.; Medtronic Co. Ltd.; World Heart Corporation; Thoratec Corporation; and Lifenet Health. Besides being monopolistic, the global market is a highly competitive one too.

Researchers have begun examining using 3D printing in the development of artificial organs. Organovo, a U.S. based biotech startup, focuses on 3D printing of human tissues. These are then sculpted in layers to form organs. Nano Dimension, an Israeli 3D printing company in collaboration with Accellta has successfully mixed human stem cells in printing inks. Accellta is an Israel based stem cell technology company. The striking feature of the inkjet methods of Nano Dimension is the speed at which it prints the human tissues. While most 3D printing techniques take hours to perform this task, Nano Dimension’s technology does it in a matter of seconds.

Browse Related Category Reports @ https://www.hexaresearch.com/research-category/healthcare-it-industry

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - http://www.hexaresearch.com/

Biopsy Devices Market Size, Share, Trends and Forecast to 2020 | Hexa Research

The worldwide Biopsy Devices Market is expected to grow at a nearly 6.5% CAGR over the forecast period (2012 to 2020). By 2020, the industry may report revenues worth almost USD 2.4 billion. High prevalence of infectious diseases and serious illnesses like cancer and kidney diseases can propel demand in the years to come. The removal of body tissues to rule out the growth of abnormal cells is known as biopsy. Biopsies are conducted quite frequently these days because of high incidence of deadly diseases.

Growing geriatric population is a prominent factor that may fuel the industry in the years to come. Different types of biopsies in cancer diagnosis are incision, skin, excision, and shave. Popularity of minimally invasive biopsy procedures can further contribute to global demand. The biopsy devices industry is gradually expanding in most emerging nations because of greater awareness, high incomes, investment in R&D, and high healthcare expenditure.

Browse Details of Report @ https://www.hexaresearch.com/research-report/biopsy-devices-industry 

Products and regions are two parameters based on which the global Biopsy Devices Market is categorized. According to products, the industry is divided into biopsy forceps, biopsy guidance system, needle-based biopsy guns, biopsy needles, and others. “Others” refers to biopsy punches, curettes, and brushes. Guidance systems held the highest share in 2013 owing to high prices of robotic guidance systems. Popularity of accurate & minimally invasive devices and high incidence of cancer are two key factors that drive this segment. It is influenced by technological advancements and the surging demand for user-friendly products.

Needle-based biopsy guns is a highly profitable segment because of surging demand for the same for obtaining soft tissue samples from bone marrows, kidneys, prostate glands, lungs, and breasts. Needle-based biopsy guns are further segmented into core needle, fine needle aspiration, and vacuum assisted biopsy devices. Biopsy forceps are of two types, namely hot and cold. The cold biopsy forceps segment can expand considerably in the years to come because these help prevent the onset of infectious diseases. The market for robotic guidance systems is projected to expand remarkably over the forecast period because of surging disposable incomes and substantial investments in technology.

Geographically, the global Biopsy Devices Market is classified into Europe, Asia Pacific, North America, and Rest of the World. North America held maximum shares in 2013 in terms of revenue. The region may continue dominating the overall industry throughout the forecast period because of rising prevalence of cancer and greater awareness about biopsy devices. The Asia Pacific market may grow rapidly because of a booming population and an expanding medical tourism industry. Other regional drivers are rising disposable incomes, unmet medical needs, and gradual improvements in healthcare infrastructure. Key companies operating in the worldwide industry are DTR Medical; Cardinal Health Inc.; Hologic Inc.; Devicor Medical Products Inc,; and C.R. Bard Inc.

Researchers from the University of Adelaide have developed a novel medical device that could lead to safer brain surgeries. It is a smart needle that helps spot blood vessels in the body. A miniature imaging probe placed inside a brain biopsy needle enables surgeons to see those blood vessels that are prone to risks. These needles on being inserted avoid causing fatal bleeds during the procedure.

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/medical-devices-industry

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - http://www.hexaresearch.com/

Visit Our Blog - https://hexaresearchinc.wordpress.com/

Medical Robotic Systems Market Research Report - Global Industry Analysis, Size and Forecast to 2020 | Hexa Research

The Global Medical Robotic Systems Market is projected to reach nearly USD 18 billion by 2020. In 2014, the industry stood at around USD 7.5 billion. Advancements in computerized surgical technologies, like telemedicine and bacteriobots for treating terminal cancers may fuel product demand over the forecast period (2012 to 2020). Heightened awareness, high population growth, improvements in healthcare infrastructure, and rising prevalence of lifestyle diseases are other industry drivers.

Widespread penetration of IT is yet another factor that has spurred the demand for medical robots in the world of healthcare. Greater preference for minimally invasive surgeries over the conventional ones may further contribute to overall demand in the years to come. Minimally invasive surgeries reduce the risks of infections & excessive bleeding, ensure shorter post-operative hospital stays, and lead to quicker healing.

Browse Details of Report @ https://www.hexaresearch.com/research-report/medical-robotic-systems-industry 

The overall Medical Robotic Systems Market is categorized on the basis of products, applications, and regions. Products comprise emergency response robotic systems, hospital & pharmacy robots, noninvasive radiosurgery robots, rehabilitation robots, and surgical robots. Surgical robots held a 3/5th share in overall revenues in 2014. Rapid adoption of these in hospitals and growing preference for minimally invasive surgeries are factors that fuel this segment. Laparoscopy robotic systems, orthopedic surgical robots, neurological surgical systems, and steerable robotic catheters are different types of surgical robots. Rehabilitation robots are of various types, namely prosthetic, assistive robots, exoskeleton robotic systems, orthotics, and therapeutic robots.

On the basis of applications, the overall industry is divided into four key areas, namely laparoscopy, neurology, special education, and orthopedics. In orthopedics, medical robots are used in surgical systems, such as iBlock, Stanmore sculptor, robodoc, ZAKO RIO, and navio PFS. The special education segment comprises surgical systems, like pathfinder, neuromate, and renaissance. Laparoscopy is further segmented into freeHand endoscope holder system, ALF-X surgical system, and da vinci robotic surgery system. With a share nearly 89%, laparoscopy was by far the largest application segment in 2014.

Geographically, the global medial robotic systems industry is classified into Asia Pacific, Europe, North America, and Rest of the World. Fueled by sophisticated medical infrastructure, high healthcare spending, and surging income levels, North America dominates the global market. Other regional drivers are growing geriatric population, high rate of market penetration, and favorable government & NGO initiatives. Asia Pacific is expected to grow at a nearly 14% CAGR till 2020. The region may be propelled by the expanding the Medical Robotic Systems Market in China & India in the forthcoming years. These emerging economies are primarily driven by rapid proliferation of hospitals, widespread awareness about medical robots, and high healthcare spending.

Prominent companies operating in the worldwide Medical Robotic Systems Market are Intuitive Surgical Inc,; MAKO Surgical Corp.; iRobot Corporation; Medrobotics Corporation; and Varian Medical Systems among various others. Recently, a group of eye surgeons successfully injected a thrombolytic drug directly into the retinal vein of a patient in order to dissolve a blood clot. Any retina-based procedure is usually very complex since retinal veins are as thin as human hair. Researchers from a Belgium based university have developed a surgical robot that can treat retinal vein occlusion. This is a condition that leads to loss of vision and in some cases, even blindness.

Browse Related Category Market Reports @

https://www.hexaresearch.com/research-category/medical-devices-industry

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - http://www.hexaresearch.com/

Visit Our Blog : https://hexaresearchinc.wordpress.com/

Sleep Apnea Devices Market : Global Industry Growth, Trends And Forecasts to 2020: Hexa Research

The global Sleep Apnea Devices Market is projected to reach approximately USD 7 billion by 2020. The market was valued at nearly USD 2 billion in 2013. It may expand at a CAGR over 10% during the forecast period (2014 to 2020). High incidence of sleep related & lifestyle disorders drives product demand. Demand may surge considerably over the forecast period due to prevalence of lifestyle disorders triggered by sleep apnea. These lifestyle disorders are hypertension, atrial fibrillation, diabetes, obesity, and congestive heart failure among others. Growing geriatric population is also a key market driver since sleep disorders are common among the elderly. Improvements in healthcare infrastructure and awareness about type II diabetes, hypertension, and stroke could positively impact the industry over the next couple of years.   

The global Sleep Apnea Devices Market is segmented on the basis of products and regions. Based on products, the industry is bifurcated into diagnostic devices and therapeutic devices. Diagnostic devices are further segmented into actigraphy systems, PSG (polysomnography) devices, single channel screening devices (or pulse oximeters), and respiratory polygraph. Over the past couple of years, demand for PSG devices has been quite high. This attributes to the fact that for sleep tests, patients prefer their homes to the laboratories. Besides being cost effective, PSG devices rank high on convenience.

Browse Details of Report @ https://www.hexaresearch.com/research-report/sleep-apnea-devices-industry

Different types of therapeutic devices are oxygen devices, oral appliances, PAP (positive airway pressure) devices, ASV (adaptive servo ventilation) systems, airway clearance systems, and others. “Oral appliances” is a rapidly expanding segment since these are used for treating moderate sleep apnea. The treatment of obstructive sleep apnea (OSA) involves oral appliances that are generally prescribed by oral surgeons, ENT specialists, or dentists. Surging demand for PAP devices could significantly contribute to market progress. Treatment of sleep disorders and airway management are two key applications of PAP devices.

Based on geographies, the global Sleep Apnea Devices Market is categorized into Europe, Asia Pacific, North America, and Rest of the World (RoW). The overall industry is led by North America. Factors that fuel this region are rising income levels, widespread awareness about sleep apnea, high insurance coverage, the problem of obesity, and a well developed healthcare infrastructure. Asia Pacific may expand favorably at a nearly 11% CAGR during the forecast period. The region is propelled by favorable government initiatives, economic development, and a rapidly growing population.
Prominent companies operating in the worldwide Sleep Apnea Devices Market are Natus Medical, ResMed, Weinmann Medical Devices, DeVilbiss Healthcare, and CareFusion among others. Mandibular Advancement Device is an oral appliance developed by Refresh Snoring and Sleep Apnea Center, U.S. This device finds the forward position of the patient’s jaw that helps maximize airflow and holds the jaw right there, when the patient is asleep. It is an easy-to-use wearable device that patients can effectively use while moving around. It doesn’t create any humming machine noise that is often made by most sleep apnea devices. Around fifteen independent case studies have shown the clinical benefits of the Mandibular Advancement Device, with more than 90% patients having reported improved sleep.

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/medical-devices-industry

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - http://www.hexaresearch.com/

Visit our Blog: https://hexaresearchinc.wordpress.com/